Melvin Parasram, DO, MS (@mel_para) 's Twitter Profile
Melvin Parasram, DO, MS

@mel_para

Neurointensivist 🧠 @nyphospital Queens | @NeurologyYale NCC Fellowship ‘23| @WCMCneurology Residency ‘21 | @midwesternuniv ‘17 | Bx 🙅🏾‍♂️ 🗽| 🇬🇾 |#GirlDad

ID: 1335025152

calendar_today07-04-2013 20:37:05

1,1K Tweet

1,1K Followers

1,1K Following

Melvin Parasram, DO, MS (@mel_para) 's Twitter Profile Photo

Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage | New England Journal of Medicine nejm.org/doi/full/10.10…

Stephan A Mayer (@stephanamayer) 's Twitter Profile Photo

Tranexamic acid vs placebo within 2 h of #ICH onset (STOP-MSU): an international, double-blind, trial Primary outcome measure was ICH growth. Turns out that TXA has absolutely NO effect on ICH expansion, which was ~30% in both groups. Zilch. Nada. thelancet.com/journals/laneu…

The Lancet (@thelancet) 's Twitter Profile Photo

Global study in The Lancet Public Health reveals stark differences in major causes of disease burden between females and males, underscoring the need for gender-responsive approaches to health. hubs.li/Q02vFZ2m0

Global study in <a href="/TheLancetPH/">The Lancet Public Health</a> reveals stark differences in major causes of disease burden between females and males, underscoring the need for gender-responsive approaches to health. hubs.li/Q02vFZ2m0
Melvin Parasram, DO, MS (@mel_para) 's Twitter Profile Photo

Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial - The Lancet Neurology thelancet.com/journals/laneu…

Melvin Parasram, DO, MS (@mel_para) 's Twitter Profile Photo

Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation jamanetwork.com/journals/jaman…

NEJM (@nejm) 's Twitter Profile Photo

Presented at #CCR24: In a new trial, a liberal transfusion strategy did not reduce the risk of an unfavorable neurologic outcome at 6 months in patients with moderate or severe traumatic brain injury and anemia. Read the full HEMOTION trial results: nej.md/3VaQhZa

Presented at #CCR24: 

In a new trial, a liberal transfusion strategy did not reduce the risk of an unfavorable neurologic outcome at 6 months in patients with moderate or severe traumatic brain injury and anemia. Read the full HEMOTION trial results: nej.md/3VaQhZa
Melvin Parasram, DO, MS (@mel_para) 's Twitter Profile Photo

Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage | New England Journal of Medicine nejm.org/doi/10.1056/NE…

Brian Edlow (@comarecoverylab) 's Twitter Profile Photo

How many patients with severe brain injuries have we examined who appeared unresponsive, and we assumed they were unconscious? International James S. McDonnell Foundation study in NEJM suggests that 25% were covertly conscious: nejm.org/doi/full/10.10… Profound clinical & ethical implications...

Lea Alhilali, MD (@teachplaygrub) 's Twitter Profile Photo

Have MULTIPLE questions about MULTIPLE sclerosis? Having trouble seeing neuromyelitis optica? In a fog about MOG? Here’s the cheat sheet you NEED to distinguish the demyelinating diseases! Demyelinating diseases predominantly involve the optic nerves, brain, & spine. Three

Have MULTIPLE questions about MULTIPLE sclerosis?

Having trouble seeing neuromyelitis optica?

In a fog about MOG?

Here’s the cheat sheet you NEED to distinguish the demyelinating diseases!

Demyelinating diseases predominantly involve the optic nerves, brain, &amp; spine.

Three
Melvin Parasram, DO, MS (@mel_para) 's Twitter Profile Photo

Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury | New England Journal of Medicine nejm.org/doi/abs/10.105…